Market Overview

Vasomotor Symptoms of Menopause | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest pipeline analysis report on the
drug pipeline for vasomotor
symptoms of menopause
. The report includes a detailed analysis
of the pipeline molecules under investigation within the defined data
collection period to treat vasomotor.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for vasomotor symptoms of meno ...

Technavio has published a new report on the drug development pipeline for vasomotor symptoms of menopause, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Vasomotor symptoms: Market overview

Vasomotor symptoms include night sweats and hot flashes and are
described as a sudden increase in the blood flow, often to the face,
neck, and chest, which causes the sensation of extreme heat and profuse

According to a senior market research analyst at Technavio, "Vasomotor
symptoms of menopause occur due to hormonal changes in a woman's body,
which happen post menopause. Some women face these symptoms more often
due to smoking, obesity, and their ethnic background."

Vasomotor symptoms of menopause:
Segmentation analysis

This pipeline analysis report segments the vasomotor market based on
therapies employed (monotherapy and combination therapy), RoA (oral and
intranasal), therapeutic modality (small molecule and protein), targets
(estrogen receptor, progesterone receptor, granulocyte, NK-1,3 receptor,
G-protein-coupled receptor, and chemokine receptor CXCR4), MoA (estrogen
receptor modulator, progesterone receptor agonist, granulocyte
stimulator, NK-1,3 receptor antagonist, and chemokine receptor CXCR4
inhibitor), geographical segmentation (US, Germany, and Canada) and
recruitment status (active, not recruiting, not yet recruiting, and
recruiting). It provides an in-depth analysis of the prominent factors
influencing the market, including drivers, opportunities, trends, and
industry-specific challenges.

Based on therapeutic modality, more than 58% of the molecules that are
being investigated for the treatment of vasomotor are small molecules,
which is a chemically manufactured active substance that can enter cells

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!